Restalyst, a member of the Reste Group, is a privately-owned biomedical clinical diagnostic company from Singapore with a regional presence in Asia.


Established in 2007, Restalyst is a trusted provider of innovative, reliable and clinically-proven diagnostic solutions to the medical and healthcare industry. We are a fully integrated company that generates the full product pipelines from scientific research to in-house developmental work of patented technology. Our key products include immunoassays for early diagnosis and sensitive detection of oncology, infectious, neurodegenerative and other diseases. Our R&D and production facilities are certified for compliance to EN ISO13485:2012.


We are committed to our mission of harnessing technological advancements for the improvement of disease diagnosis and management of patient health. Through various collaborations with healthcare professionals and institutions globally, our dynamic team continuously pushes the boundaries of R&D to produce quality diagnostic solutions that are of high accuracy and sensitivity.